57 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
2021 ACR/VF Guidelines ... for Management ... of Giant Cell Arteritis ... ) #GiantCell #Arteritis ... #rheumatology #
Guidelines on De-Prescribing of Proton Pump Inhibitors

Best Practice Advice Statements
Long-term Indications for PPI use
Short-term Indications for
Guidelines on De-Prescribing ... Indications for PPI ... Indications for PPI ... EmoryGastroHep #DePrescribing ... #Guidelines #management
Proton Pump Inhibitor (PPI) - Adverse Effects and Prescribing Tips

#Management #Pharmacology #PPI #Adverse #SideEffects #Prescribing #ProtonPumpInhibitor
Pump Inhibitor (PPI ... Adverse Effects and Prescribing ... Tips #Management ... #Pharmacology #PPI ... #SideEffects #Prescribing
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid Arthritis ... - ACR 2021 Guidelines ... #ACR2021 #Guidelines ... #management #treatment ... #rheumatology
Deprescribing algorithm for proton pump inhibitors

To support clinicians in employing the recommendations outlined in the guideline,
Deprescribing algorithm ... outlined in the guideline ... #Management #Geriatrics ... #PPI #ProtonPumpInhibitors ... #Deprescribing
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... • Giant Cell Arteritis ... • Takayasu's arteritis ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Rheumatoid Arthritis Summary
MCP and PIP Involvement, Spares DIP, Carpal Tunnel, Sicca Syndrome, Epi/Scleritis, Heart Disease, Rheumatoid
Rheumatoid Arthritis ... Summary MCP and PIP ... Sicca Syndrome, Epi ... #Rheumatoid #Arthritis ... RA #diagnosis #rheumatology
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Svoboda Ref: NCCN guidelines ... Lymphoma #oncology #Hematology ... #management #treatment ... #guideline
Giant Cell (Temporal) Arteritis

Dr. Ann Marie Kumfer @AnnKumfer

#GiantCell #Temporal #Arteritis #Diagnosis #Management #GCA #rheumatology
Cell (Temporal) Arteritis ... GiantCell #Temporal #Arteritis ... #Diagnosis #Management ... #GCA #rheumatology
Cholinesterase Inhibitor (ChEl) and Memantine Deprescribing Algorithm 

To support health care professionals in employing the recommendations
and Memantine Deprescribing ... outlined in the guideline ... developed a two-page deprescribing ... #Management #Geriatrics ... Cholinesterase #Inhibitors #Deprescribing